Antifungal effect of various essential oils against Candida albicans.: Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris

被引:147
作者
Giordani, R
Regli, P
Kaloustian, J
Mikaïl, C
Abou, L
Portugal, H
机构
[1] Fac Pharm Marseille, Lab Bot Cryptogamie & Biol Cellulaire, F-13385 Marseille 05, France
[2] CNRS, IBSM, LCB, UPR 9043, F-13402 Marseille 20, France
[3] Univ Mediterranee, Fac Pharm, Chim Analyt Lab, Marseille, France
[4] Univ Mediterranee, Fac Med, INSERM, Unite 476, Marseille, France
关键词
antifungal actions; Candida albicans; amphotericin B; essential oils; GC/MS;
D O I
10.1002/ptr.1594
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The antifungal effect of the essential oil from Satureja montana L., Lavandula angustifolia Mill., Lavandula hybrida Reverchon, Syzygium aromaticum (L.) Merril and Perry, Origanum vulgare L., Rosmarinus officinalis L. and six chemotypes of Thymus vulgaris L. on Candida albicans growth were studied. The most efficiency was obtained with the essential oil from Thymus vulgaris thymol chemotype (MIC 80% = 0.016 muL/mL and K-aff = 296 muL/mL). The presence in the culture medium of essential oil from Thymus vulgaris thymol chemotype (0.01, 0.1, 0.2, 0.3 mug/mL) and amphotericin B involved a decrease of the MIC 80% of amphotericin B. In contrast, the combination of amphotericin B and low concentrations (0.00031-0.0025 mug/mL) of essential oil was antagonistic. The strongest decrease (48%) of the MIC 80% was obtained with medium containing 0.2 muL/ mL of essential oil. These results signify that the essential oil of Thymus vulgaris thymol chemotype potentiates the antifungal action of amphotericin B suggesting a possible utilization of this essential oil in addition to antifungal drugs for the treatment of mycoses. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:990 / 995
页数:6
相关论文
共 23 条
[1]   CHEMOTHERAPY OF SYSTEMIC MYCOSES (FIRST OF 2 PARTS) [J].
BENNETT, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (01) :30-32
[2]   CANDIDA-ALBICANS BIOTYPES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH ORAL CANDIDIASIS BEFORE AND AFTER ANTIFUNGAL THERAPY [J].
BRUATTO, M ;
VIDOTTO, V ;
MARINUZZI, G ;
RAITERI, R ;
SINICCO, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (04) :726-730
[3]   NEPHROTOXICITY OF AMPHOTERICIN B - EARLY + LATE EFFECTS IN 81 PATIENTS [J].
BUTLER, WT ;
BENNETT, JE ;
WERTLAKE, PT ;
UTZ, JP ;
ALLING, DW ;
HILL, GJ .
ANNALS OF INTERNAL MEDICINE, 1964, 61 (02) :175-+
[4]   The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil) [J].
Cox, SD ;
Mann, CM ;
Markham, JL ;
Bell, HC ;
Gustafson, JE ;
Warmington, JR ;
Wyllie, SG .
JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 (01) :170-175
[5]   In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi [J].
D'Auria, FD ;
Laino, L ;
Strippoli, V ;
Tecca, M ;
Salvatore, G ;
Battinelli, L ;
Mazzanti, G .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (04) :377-383
[6]   INVITRO SYNERGY AND ANTAGONISM OF ANTIFUNGAL AGENTS AGAINST YEAST-LIKE FUNGI [J].
DUPONT, B ;
DROUHET, E .
POSTGRADUATE MEDICAL JOURNAL, 1979, 55 (647) :683-686
[7]   DEVELOPMENT OF RESISTANCE IN CANDIDA ISOLATES FROM PATIENTS RECEIVING PROLONGED ANTIFUNGAL THERAPY [J].
FANHAVARD, P ;
CAPANO, D ;
SMITH, SM ;
MANGIA, A ;
ENG, RHK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2302-2305
[8]  
GIORDANI R, 1991, MYCOSES, V34, P469, DOI 10.1111/j.1439-0507.1991.tb00862.x
[9]  
Giordani R, 2003, J MYCOL MED, V13, P87
[10]  
Giordani R, 2003, J MYCOL MED, V13, P24